Codrin I. Lungu
Affiliations: | National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States |
Area:
Movement DisordersGoogle:
"Codrin Lungu"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rocco MT, Akhter AS, Ehrlich DJ, et al. (2023) Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Lungu C, Nmashie A, George MC, et al. (2022) Comparison of Ultrasound and Electrical Stimulation Guidance for Onabotulinum Toxin-A Injections: A Randomized Crossover Study. Movement Disorders Clinical Practice. 9: 1055-1061 |
| Rocco MT, Akhter AS, Ehrlich DJ, et al. (2022) Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of patients with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Hattori T, Reynolds R, Wiggs E, et al. (2022) Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease. Neuroimage. Clinical. 35: 103100 |
| Vanegas-Arroyave N, Chen DF, Lauro PM, et al. (2022) Where Do Parkinson's Disease Patients Look while Walking? Movement Disorders : Official Journal of the Movement Disorder Society |
| Kilic-Berkmen G, Wright LJ, Perlmutter JS, et al. (2021) The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies. Frontiers in Neurology. 12: 660909 |
| Barker RA, Bjorklund A, Gash DM, et al. (2020) GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease |
| Lungu C, Ozelius L, Standaert D, et al. (2020) Defining research priorities in dystonia. Neurology |
| Staffaroni AM, Bajorek L, Casaletto KB, et al. (2020) Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 11-21 |
| Park JE, Shamim EA, Panyakaew P, et al. (2019) Botulinum toxin and occupational therapy for Writer's Cramp. Toxicon : Official Journal of the International Society On Toxinology |